Kevin Feeley's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 5,278 Class A Common Stock done at an average price of $93 . Disclosure was reported to the exchange on July 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.00 per share. | 09 Jul 2025 | 5,278 | 3,392 | - | 93 | 490,854 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,245 | 6,228 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.67 per share. | 09 Jul 2025 | 1,245 | 8,670 | - | 32.7 | 40,674 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 90.86 per share. | 01 Jul 2025 | 998 | 7,771 | - | 90.9 | 90,680 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 91.88 per share. | 01 Jul 2025 | 346 | 7,425 | - | 91.9 | 31,791 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 7,197 | 50,378 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 7,197 | 12,498 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.77 per share. | 16 Jun 2025 | 3,729 | 8,769 | - | 64.8 | 241,539 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 2,462 | 14,773 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 2,462 | 6,567 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 72.55 per share. | 09 Jun 2025 | 1,266 | 5,301 | - | 72.5 | 91,848 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 718 | 4,475 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 718 | 3,586 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 71.26 per share. | 01 Jun 2025 | 370 | 4,105 | - | 71.3 | 26,366 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2025 | 753 | 3,725 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2025 | 753 | 3,014 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 56.82 per share. | 29 Apr 2025 | 420 | 3,757 | - | 56.8 | 23,865 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 113.09 per share. | 29 Apr 2025 | 388 | 3,337 | - | 113.1 | 43,879 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.26 per share. | 09 Apr 2025 | 6,810 | 7,177 | - | 93.3 | 635,112 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.28 per share. | 09 Apr 2025 | 5,993 | 7,994 | - | 93.3 | 559,010 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 94.60 per share. | 09 Apr 2025 | 3,122 | 4,055 | - | 94.6 | 295,335 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 94.61 per share. | 09 Apr 2025 | 2,693 | 5,301 | - | 94.6 | 254,774 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 95.53 per share. | 09 Apr 2025 | 1,463 | 2,592 | - | 95.5 | 139,758 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 95.53 per share. | 09 Apr 2025 | 1,463 | 3,838 | - | 95.5 | 139,758 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2025 | 1,246 | 7,473 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.67 per share. | 09 Apr 2025 | 1,246 | 17,242 | - | 32.7 | 40,707 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.67 per share. | 09 Apr 2025 | 1,246 | 17,242 | - | 32.7 | 40,707 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2025 | 1,246 | 7,473 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 84.61 per share. | 09 Apr 2025 | 1,198 | 15,407 | - | 84.6 | 101,359 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 84.61 per share. | 09 Apr 2025 | 1,198 | 15,407 | - | 84.6 | 101,359 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 85.73 per share. | 09 Apr 2025 | 1,171 | 14,236 | - | 85.7 | 100,391 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 85.73 per share. | 09 Apr 2025 | 1,171 | 14,236 | - | 85.7 | 100,391 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 96.46 per share. | 09 Apr 2025 | 846 | 1,746 | - | 96.5 | 81,603 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 96.46 per share. | 09 Apr 2025 | 846 | 2,992 | - | 96.5 | 81,603 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 83.67 per share. | 09 Apr 2025 | 637 | 16,605 | - | 83.7 | 53,297 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 83.67 per share. | 09 Apr 2025 | 637 | 16,605 | - | 83.7 | 53,297 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 86.48 per share. | 09 Apr 2025 | 249 | 13,987 | - | 86.5 | 21,534 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 86.48 per share. | 09 Apr 2025 | 249 | 13,987 | - | 86.5 | 21,534 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 97.25 per share. | 09 Apr 2025 | 20 | 1,726 | - | 97.3 | 1,945 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 97.25 per share. | 09 Apr 2025 | 20 | 2,972 | - | 97.3 | 1,945 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 16,250 | 24,742 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 16,250 | 48,750 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 95.66 per share. | 26 Mar 2025 | 8,418 | 16,324 | - | 95.7 | 805,247 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 94.40 per share. | 26 Mar 2025 | 328 | 15,996 | - | 94.4 | 30,964 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 2,462 | 6,368 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 2,462 | 17,235 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 94.72 per share. | 09 Mar 2025 | 922 | 5,446 | - | 94.7 | 87,334 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 717 | 4,034 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 717 | 4,167 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 103.94 per share. | 01 Mar 2025 | 261 | 3,906 | - | 103.9 | 27,128 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2025 | 753 | 3,225 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2025 | 753 | 3,767 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 78.48 per share. | 29 Jan 2025 | 275 | 2,950 | - | 78.5 | 21,582 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 02 Jan 2025 | 774 | 27,107 | - | 76 | 58,824 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.04 per share. | 02 Jan 2025 | 337 | 26,770 | - | 77.0 | 25,963 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 75.08 per share. | 02 Jan 2025 | 319 | 27,881 | - | 75.1 | 23,949 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 7,197 | 64,772 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 7,197 | 31,928 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.75 per share. | 16 Dec 2024 | 3,728 | 28,200 | - | 76.8 | 286,139 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 2,462 | 25,868 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 2,462 | 19,697 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.37 per share. | 09 Dec 2024 | 1,137 | 24,731 | - | 76.4 | 86,836 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 718 | 5,021 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 718 | 23,669 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 78.39 per share. | 01 Dec 2024 | 263 | 23,406 | - | 78.4 | 20,617 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 73.79 per share. | 21 Nov 2024 | 5,524 | 36,771 | - | 73.8 | 407,608 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 75.34 per share. | 21 Nov 2024 | 5,162 | 27,770 | - | 75.3 | 388,927 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 74.97 per share. | 21 Nov 2024 | 3,839 | 32,932 | - | 75.0 | 287,791 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.41 per share. | 21 Nov 2024 | 2,711 | 25,059 | - | 76.4 | 207,149 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.40 per share. | 21 Nov 2024 | 2,108 | 22,951 | - | 77.4 | 163,166 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 73.00 per share. | 21 Nov 2024 | 1,057 | 42,295 | - | 73.0 | 77,162 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 71.86 per share. | 21 Nov 2024 | 969 | 43,352 | - | 71.9 | 69,629 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.84 per share. | 21 Nov 2024 | 430 | 44,321 | - | 70.8 | 30,463 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 69.58 per share. | 21 Nov 2024 | 200 | 44,751 | - | 69.6 | 13,915 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2024 | 753 | 4,520 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2024 | 753 | 45,225 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 66.60 per share. | 29 Oct 2024 | 274 | 44,951 | - | 66.6 | 18,248 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 7,197 | 71,969 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 7,197 | 47,107 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 16 Sep 2024 | 2,635 | 44,472 | - | 37.6 | 99,050 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 2,462 | 22,159 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 2,462 | 40,805 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 09 Sep 2024 | 895 | 39,910 | - | 33.3 | 29,830 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 717 | 5,739 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 717 | 38,605 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.71 per share. | 01 Sep 2024 | 262 | 38,343 | - | 31.7 | 8,308 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 753 | 5,273 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 753 | 38,162 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.54 per share. | 29 Jul 2024 | 274 | 37,888 | - | 33.5 | 9,190 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 7,197 | 40,055 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 7,197 | 79,166 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.31 per share. | 16 Jun 2024 | 2,646 | 37,409 | - | 28.3 | 74,908 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2024 | 2,462 | 24,621 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2024 | 2,462 | 33,753 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.92 per share. | 09 Jun 2024 | 895 | 32,858 | - | 24.9 | 22,303 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 717 | 6,456 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 717 | 31,553 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 01 Jun 2024 | 262 | 31,291 | - | 20.5 | 5,384 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 3,013 | 31,940 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 3,013 | 6,026 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.04 per share. | 29 Apr 2024 | 1,104 | 30,836 | - | 11.0 | 12,185 | Class A Common Stock |